Company intelligence / Profile preview

R&D Systems

Minneapolis, Minnesota, USArndsystems.com ↗

Ownership: Private
Employees: ~600
Development stage: Commercial

Overview

R&D Systems is a leading global provider of high-quality biological reagents—including proteins (notably cytokines), antibodies (monoclonal/polyclonal/recombinant), ELISA kits/assays/multiplex assays—and clinical controls/calibrators. Their products enable basic life science discovery through to clinical diagnostics. The company is recognized for pioneering commercial production of TGF-beta 1 and remains an industry leader in immunoassays and protein tools.

Therapeutic areas: OncologyImmunologyOtherCardiovascularNeurology
Modalities: ProteinRecombinant proteinMonoclonal antibodyPolyclonal antibodySmall moleculePeptides
Industry: Protein Biomarker Diagnostics

Partnerships

PROGEN (AAV ELISA assays)Academic institutionsNobel laureates

Beyond the preview

Go deeper on R&D Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on R&D Systems.

Explore the full profile